{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&_page=0&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1148165", "AnsweringBody" : [{"_value" : "Department for Transport"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148165/answer", "answerText" : {"_value" : "
The Future of Mobility regulatory review is a once in a generation opportunity to ensure our regulatory framework supports transport innovation.<\/p>
<\/p>
The first key milestone will be a call for evidence which we plan to launch in autumn this year. We will use the responses to identify where reform is needed now to address areas with a pressing need for change. The responses will also help the Government clarify where further work is necessary ahead of more substantial changes to legislation over the next few years.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T09:27:31.347Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "27"} , "answeringDeptShortName" : {"_value" : "Transport"} , "answeringDeptSortName" : {"_value" : "Transport"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Electric Scooters"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Transport, what the timeframe is for the publication of the Future of Mobility regulatory review.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"} } , "tablingMemberConstituency" : {"_value" : "Totnes"} , "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"} ], "uin" : "294143"} , {"_about" : "http://data.parliament.uk/resources/1148172", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148172/answer", "answerText" : {"_value" : "
The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.<\/p>
The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>
<\/p>
https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a><\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-08T13:51:02.857Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availability of medicines in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"}
}
, "tablingMemberConstituency" : {"_value" : "Totnes"}
, "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"}
], "uin" : "294144"}
, {"_about" : "http://data.parliament.uk/resources/1148176", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1148176/answer", "answerText" : {"_value" : " Operation Yellowhammer is a cross-Government programme of work to ensure that the United Kingdom is prepared to deal with the potential reasonable worst-case scenario impacts of leaving the European Union without a deal.<\/p> <\/p> On 11 September, the Government published planning assumptions for exiting the European Union without a deal at the following link:<\/p> https://www.gov.uk/government/publications/government-response-to-humble-address-motion<\/a><\/p> <\/p> An updated version will be published in due course.<\/p> <\/p> These include the Department\u2019s planning assumptions relating to the continuity of medicines and medicine supplies, the provision of healthcare to UK nationals within EU Member States, and the provision of adult social care after we have left the EU. The Department maintains robust operational plans to ensure the continuity of services from the National Health Service and wider health and social care system, regardless of circumstances, and will continue to do so.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-08T10:22:25.277Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Department of Health and Social Care: Brexit"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will publish the Government's worst case contingency plans related to his remit on the UK's withdrawal from the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"}
}
, "tablingMemberConstituency" : {"_value" : "Totnes"}
, "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"}
], "uin" : "294145"}
, {"_about" : "http://data.parliament.uk/resources/1146812", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1146812/answer", "answerText" : {"_value" : " Safety must always be paramount in technological developments and there is no credible evidence 5G is harmful to human health. All proposed 5G Testbeds and Trials (5GTT) projects have to comply with the guidelines published by the International Commission on Non-Ionizing Radiation Protection. ICNIRP is formally recognised by the World Health Organization. Public Health England\u2019s Centre for Radiation, Chemical and Environmental Hazards takes the lead on public health matters associated with radiofrequency electromagnetic fields, or radio waves.<\/p> <\/p> The 5GTT has strict expectations that all grant funded projects will adhere to ICNIRP guidelines. A considerable amount of research has been carried out on radio waves and per PHE\u2019s advice we anticipate no negative effects on public health.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4361", "label" : {"_value" : "Biography information for Matt Warman"}
}
, "answeringMemberConstituency" : {"_value" : "Boston and Skegness"}
, "answeringMemberPrinted" : {"_value" : "Matt Warman"}
, "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-08T11:11:56.967Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "10"}
, "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "date" : {"_value" : "2019-09-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "5G"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, what steps she is taking to introduce safety tests on the proposed 5G pilot projects.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"}
}
, "tablingMemberConstituency" : {"_value" : "Totnes"}
, "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"}
], "uin" : "291573"}
, {"_about" : "http://data.parliament.uk/resources/1146813", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1146813/answer", "answerText" : {"_value" : " Public Health England (PHE) has published a webpage about exposure to the radio waves from mobile phone base stations, including those for 5G networks, at the following link:<\/p>
<\/p><\/td> | 2014-15<\/p><\/td> | 2015-16<\/p><\/td> | 2016-17<\/p><\/td> | 2017-18<\/p><\/td> | 2018-19<\/p><\/td><\/tr> |
Foundation Trust CDEL Outturn Expenditure (£,000s)<\/p><\/td> | 1,925,555<\/p><\/td> | 1,795,693<\/p><\/td> | 1,815,837<\/p><\/td> | 2,061,023<\/p><\/td> | 2,380,091<\/p><\/td><\/tr> |
NHS Trust CDEL Outturn Expenditure (£,000s)<\/p><\/td> | 1,381,276<\/p><\/td> | 1,146,203<\/p><\/td> | 1,049,501<\/p><\/td> | 1,002,017<\/p><\/td> | 1,551,799<\/p><\/td><\/tr> |
Total NHS Provider CDEL Outturn Expenditure (£,000s)<\/p><\/td> | 3,306,831<\/p><\/td> | 2,941,896<\/p><\/td> | 2,865,338<\/p><\/td> | 3,063,040<\/p><\/td> | 3,931,890<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4021", "label" : {"_value" : "Biography information for Chris Skidmore"} } , "answeringMemberConstituency" : {"_value" : "Kingswood"} , "answeringMemberPrinted" : {"_value" : "Chris Skidmore"} , "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-09-09T14:54:15.707Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-09-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Capital Investment"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much capital funding has been (a) allocated to and (b) spent by (i) NHS foundation trusts and (ii) NHS trusts per capita in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4073", "label" : {"_value" : "Biography information for Dr Sarah Wollaston"} } , "tablingMemberConstituency" : {"_value" : "Totnes"} , "tablingMemberPrinted" : [{"_value" : "Dr Sarah Wollaston"} ], "uin" : "286728"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Dr+Sarah+Wollaston&_page=1&max-ddpModified.=2019-10-08T09%3A59%3A04.635Z", "page" : 0, "startIndex" : 1, "totalResults" : 323, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} } |